Amsbio has expanded its range of high-quality FFPE tissues and controls specifically designed to support biomarker discovery, histopathology, translational research and assay development. Although the tissue structure in FFPE samples is maintained for histological analysis, damage to the RNA incurred through the fixation, embedding, and storage processes advances with time and storage temperature. Sub-optimal tissue […]

New capillary electrophoresis instrument triples sample throughput for DNA laboratories using 5-, 6- or 8-dye chemistry for casework, database and paternity samples MADISON, Wis. — Promega Corporation has launched a 24-capillary model of the Spectrum CE System for DNA typing, including forensic analysis. Spectrum CE Systems are the only capillary electrophoresis (CE) instruments designed and […]

PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models MENLO PARK, Calif. and PARIS — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a collaboration to generate full-length RNA data that TychoBio will use to train models […]

HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and new product roadmaps. The SAB will meet quarterly and consists of five members, Harvard Bioscience President and CEO John Duke and four experienced industry leaders. “The formation of our […]

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery workflows QIAGEN builds on more than 25 years of biomedical knowledge, with QDI tools used by around 150,000 users VENLO, Netherlands & GERMANTOWN, Md. — QIAGEN N.V. […]

Collaboration brings EpiSign’s comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform LONDON, ON and HERZLIYA, Israel — EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease interpretation. The collaboration combines EpiSign’s expertise in DNA methylation episignature analysis […]

BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its Microfluidics business to ARCHIMED (“ARCHIMED”), a leading investment firm focused exclusively on healthcare industries. Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools, said, “ARCHIMED brings deep healthcare […]

Building a two-site demonstration laboratory system together with the semiconductor-focused facility in Bengaluru, Hitachi High-Tech aims to strengthen the provision of digitalized assets in the India market and also accelerating HMAX Industry TOKYO — Hitachi High-Tech Corporation (“Hitachi High-Tech”), has established a demonstration laboratory Advanced-Technology Innovation Center Mumbai for analytical systems in Mumbai, India (“Mumbai […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that, effective today, Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and has joined Danaher’s Board of Directors, as previously announced on August 3, 2026. Since joining the Company in 2017, Ms. Sawyer Montgomery has held roles of increasing responsibility […]

New software extends automated analysis of more than 300 episignature disorders beyond methylation microarrays to Illumina 5-base, PacBio HiFi and Oxford Nanopore sequencing data LONDON, ONTARIO — EpiSign Inc. today announced the launch of EpiSign METRIC 5-base, extending its comprehensive and automated episignature analysis framework beyond methylation microarrays to sequencing-derived DNA methylation data. EpiSign METRIC […]